DK618088D0 - Farmaceutisk doseringsform til kontrolleret afgivelse af aktivt stof - Google Patents

Farmaceutisk doseringsform til kontrolleret afgivelse af aktivt stof

Info

Publication number
DK618088D0
DK618088D0 DK618088A DK618088A DK618088D0 DK 618088 D0 DK618088 D0 DK 618088D0 DK 618088 A DK618088 A DK 618088A DK 618088 A DK618088 A DK 618088A DK 618088 D0 DK618088 D0 DK 618088D0
Authority
DK
Denmark
Prior art keywords
dosage form
controlled release
medicament
active substance
pharmaceutical dosage
Prior art date
Application number
DK618088A
Other languages
English (en)
Other versions
DK175249B1 (da
DK618088A (da
Inventor
Masayoshi Samejima
Kazuo Noda
Masao Kobayashi
Shigeyuki Ishikawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of DK618088D0 publication Critical patent/DK618088D0/da
Publication of DK618088A publication Critical patent/DK618088A/da
Application granted granted Critical
Publication of DK175249B1 publication Critical patent/DK175249B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198806180A 1987-11-06 1988-11-04 Doseringsform til kontrolleret afgivelse DK175249B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28118987 1987-11-06
JP28118987 1987-11-06

Publications (3)

Publication Number Publication Date
DK618088D0 true DK618088D0 (da) 1988-11-04
DK618088A DK618088A (da) 1989-05-07
DK175249B1 DK175249B1 (da) 2004-07-19

Family

ID=17635585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806180A DK175249B1 (da) 1987-11-06 1988-11-04 Doseringsform til kontrolleret afgivelse

Country Status (24)

Country Link
US (1) US4963365A (da)
EP (1) EP0315414B1 (da)
KR (1) KR940002655B1 (da)
CN (1) CN1035099C (da)
AT (1) ATE68343T1 (da)
AU (1) AU610275B2 (da)
BG (1) BG60638B1 (da)
CA (1) CA1331565C (da)
DE (1) DE3865631D1 (da)
DK (1) DK175249B1 (da)
ES (1) ES2027013T3 (da)
FI (1) FI96273C (da)
FR (1) FR2622799B1 (da)
GR (1) GR3002915T3 (da)
HK (1) HK44593A (da)
HU (1) HU201468B (da)
IE (1) IE60785B1 (da)
IL (1) IL88083A (da)
NO (1) NO176233C (da)
PH (1) PH25905A (da)
PT (1) PT88945B (da)
RU (1) RU1816213C (da)
SG (1) SG15493G (da)
ZA (1) ZA888147B (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
EP0386440B1 (de) * 1989-02-11 1992-08-05 Bayer Ag Arzneimittel mit kontrollierter Wirkstoffabgabe
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
FI905731A7 (fi) * 1989-03-22 1990-11-20 Peter K T Pang Parathormonin hypertension aiheuttaja
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
DK0585355T3 (da) * 1991-05-20 1995-06-06 Tanabe Seiyaku Co Flerlagspræparat med reguleret frigivelse
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
ES2143481T3 (es) * 1992-05-29 2000-05-16 Nikken Chemicals Co Ltd Comprimido de valproato de sodio de liberacion lenta.
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
AU4219497A (en) * 1996-09-13 1998-04-02 Shionogi & Co., Ltd. Sustained-release preparation utilizing thermal change and process for the production thereof
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
JP4260370B2 (ja) * 1998-08-10 2009-04-30 旭化成ファーマ株式会社 塩酸ファスジルの経口徐放性製剤
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
WO2002085335A1 (en) * 2001-04-18 2002-10-31 Nostrum Pharmaceuticals Inc. A novel coating for a sustained release pharmaceutical composition
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
CN1296046C (zh) * 2003-12-23 2007-01-24 广州市医药工业研究所 盐酸地尔硫䓬控释胶囊剂及其制备方法
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US8088414B2 (en) 2006-02-07 2012-01-03 Fmc Corporation Latex or pseudolatex compositions, coatings and coating processes
CN104825397A (zh) 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) * 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8927010B2 (en) * 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) * 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) * 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
CA2778748A1 (en) * 2011-06-01 2012-12-01 Nitto Denko Corporation Particulate preparation and method for producing the same
FR2996418B1 (fr) * 2012-10-09 2015-05-29 Seppic Sa Compositions alimentaires comprenant des capsules obtenues par coacervation ne mettant pas en œuvre de reticulant toxique
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
MX2022010780A (es) * 2020-03-02 2022-09-26 Gruenenthal Gmbh Forma de dosificacion que proporciona liberacion prolongada de sal de acido fosforico de tapentadol.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1172087A (fr) * 1956-01-25 1959-02-05 Bellon Labor Sa Roger Perfectionnements concernant l'enrobage de préparations à effet retardé et à effet soutenu
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US4390406A (en) * 1982-07-23 1983-06-28 Allied Corporation Replaceable outer junction double junction reference electrode
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins

Also Published As

Publication number Publication date
IE60785B1 (en) 1994-08-10
AU2472788A (en) 1989-05-11
IL88083A (en) 1992-11-15
NO176233C (no) 1995-03-01
FI885101L (fi) 1989-05-07
EP0315414A1 (en) 1989-05-10
IL88083A0 (en) 1989-06-30
CN1035099C (zh) 1997-06-11
ATE68343T1 (de) 1991-11-15
RU1816213C (ru) 1993-05-15
NO176233B (no) 1994-11-21
US4963365A (en) 1990-10-16
HUT50624A (en) 1990-03-28
FR2622799A1 (fr) 1989-05-12
DK175249B1 (da) 2004-07-19
HU201468B (en) 1990-11-28
GR3002915T3 (en) 1993-01-25
FI96273C (fi) 1996-06-10
DK618088A (da) 1989-05-07
NO884947D0 (no) 1988-11-04
ES2027013T3 (es) 1992-05-16
FI96273B (fi) 1996-02-29
DE3865631D1 (de) 1991-11-21
IE883246L (en) 1989-05-06
FR2622799B1 (fr) 1991-11-29
AU610275B2 (en) 1991-05-16
FI885101A0 (fi) 1988-11-04
SG15493G (en) 1993-04-16
EP0315414B1 (en) 1991-10-16
BG85941A (bg) 1993-12-24
KR940002655B1 (ko) 1994-03-28
BG60638B1 (bg) 1995-11-30
KR890007720A (ko) 1989-07-05
NO884947L (no) 1989-05-08
PT88945A (pt) 1989-11-30
ZA888147B (en) 1990-06-27
CN1033007A (zh) 1989-05-24
CA1331565C (en) 1994-08-23
PH25905A (en) 1991-12-19
HK44593A (en) 1993-05-14
PT88945B (pt) 1993-05-31

Similar Documents

Publication Publication Date Title
DK618088A (da) Farmaceutisk doseringsform til kontrolleret afgivelse af aktivt stof
DK156289A (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
GR910100283A (el) Στερεά από του στόματος χορηγουμένη φαρμακευτική μορφή δοσιμετρήσεως προγραμματισμένου ρυ?μού απελευ?ερώσεως.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DK668787D0 (da) Flydende doseringsform til oral indgift af farmaceutisk virksomt stof
DK196189D0 (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
NO904754D0 (no) Kapsel for innkapsling av biologisk aktive materialer, fremgangsmaate for fremstilling av denne, samt anvendelse derav.
NO882406L (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
SE8701479D0 (sv) Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
DK6181A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater i tabletform med langvarig afgivelse af det virksomme stof
DK106685D0 (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
BR8009059A (pt) Administracao de substancia medicas ativas
FI880210L (fi) Menetelmä valmistaa peroraalista stabiloitua, tehoainetta hidastetusti ja kontrolloidusti vapauttavaa, lääkevalmistetta
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.
DK464686D0 (da) Praeparat med kontrolleret afgivelse af det aktive stof
LV5394A3 (lv) Panemiens arstniecibas lidzekla iegusanai ar regulejamu aktivas vielas izdalisanos

Legal Events

Date Code Title Description
PUP Patent expired